Position in DNLI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$49,144,027
+$6,697,973 QoQ
Shares Held
1,910,732
-13.6% QoQ
Ownership
1.20%
of shares outstanding
% of Portfolio
91.90%
of 13F equity value
Holder Rank
#24
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Crestline Management, L.P. holds $51,781,545 across 2 Biotechnology names. DNLI ranks #1 (94.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DNLI |
Denali Therapeutics Inc.
This page
|
1,910,732 | $49,144,027 | |
| 2 | SANA |
Sana Biotechnology, Inc.
|
755,736 | $2,637,518 |
All Filings in DNLI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,144,027 | 1,910,732 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $42,446,054 | 2,210,732 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $46,405,185 | 2,810,732 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $49,523,828 | 3,410,732 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $54,011,640 | 3,860,732 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $56,565,151 | 4,160,732 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $87,852,718 | 4,310,732 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $129,941,123 | 4,460,732 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $110,544,197 | 4,760,732 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $106,924,220 | 5,210,732 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $121,479,308 | 5,660,732 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $122,969,901 | 5,960,732 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $180,327,701 | 6,110,732 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $147,703,265 | 6,410,732 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $190,796,956 | 6,860,732 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $219,762,865 | 7,160,732 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $219,569,342 | 7,460,732 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $240,011,748 | 7,460,732 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $343,644,739 | 7,705,039 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $388,719,217 | 7,705,039 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $638,147,129 | 8,135,481 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $570,134,135 | 9,984,836 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,630,179,000 | 19,462,500 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $437,184,546 | 12,201,634 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $329,933,222 | 13,644,881 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $272,591,057 | 15,567,736 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||